The Japanese firm has agreed to make a $50 million investment in Dallas-based Taysha in exchange for a 15% stake in the company, plus exclusive options to license two clinical-stage, single-gene ...
Taysha Gene Therapies (TSHA) announced that, on March 3, 2025, the Compensation Committee of Taysha’s Board of Directors granted three new employees, in the aggregate, options to purchase ...
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been given a consensus recommendation of “Buy” by the eight ratings firms that are covering the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback